First published · Last updated
Fully human anti-FOLR1 T-cell engager demonstrates potent activity in CBFA2T3::GLIS2 acute megakaryoblastic leukemia
A peer-reviewed journal article reports that a fully human anti-FOLR1 T‑cell engager showed potent activity against the CBFA2T3::GLIS2 subtype of acute megakaryoblastic leukemia. The item is published by Elsevier BV on 2026-08-01 and no additional details were provided in the supplied source fields.
Categories: science-and-space, public-health, positive-progress
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 3/10
- Geographic reach
- 1/10
- Global importance
- 3/10
- Impact magnitude
- 4/10
- Positivity
- 7/10
- Urgency
- 2/10
Why it matters
It reports a potential therapeutic advance specific to a defined leukemia subtype.

